Effects of male reproductive toxicants on gene expression in rat testes. 2005

Tamio Fukushima, and Toshinori Yamamoto, and Rie Kikkawa, and Yoshimasa Hamada, and Masatoshi Komiyama, and Chisato Mori, and Ikuo Horii
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., Aichi.

Predictive biomarkers of testicular toxicity are needed for an efficient development of drugs. The purpose of the present study was to obtain further insight into the toxicity mechanisms of various male reproductive toxicants and to detect genomic biomarkers for rapid screening of testicular toxicity. Four reproductive toxicants, 2,5-hexanedione (Sertoli cells toxicant), ethylene glycol monomethyl ether (EGME; spermatocytes toxicant), cyclophosphamide (spermatogonia toxicant) and sulfasalazine, were orally administered to male rats once. Six hours after the single dosing, gene expression in the testes was monitored by cDNA microarray and real-time RT-PCR and the testes were histopathologically examined. No histopathological abnormality was detected except for slight degeneration of spermatocytes in the EGME-treated testes. cDNA microarray analysis revealed differential gene expression profiles, and it was possible based on the profiles to characterize the action of the compounds in the testes. Interestingly, 3 spermatogenesis-related genes -- heat shock protein 70-2, insulin growth factor binding protein 3 and glutathione S transferase pi -- were affected by all the compounds. The above changes of gene expression were detectable within a short period after the dosing prior to the appearance of obvious pathological changes. These data suggest that cDNA microarray is a useful technique for evaluation of primary testicular toxicity. Furthermore, we propose the above 3 spermatogenesis-related genes as potential biomarkers of testicular toxicity.

UI MeSH Term Description Entries
D008297 Male Males
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004822 Epididymis The convoluted cordlike structure attached to the posterior of the TESTIS. Epididymis consists of the head (caput), the body (corpus), and the tail (cauda). A network of ducts leaving the testis joins into a common epididymal tubule proper which provides the transport, storage, and maturation of SPERMATOZOA.
D005026 Ethylene Glycols An ethylene compound with two hydroxy groups (-OH) located on adjacent carbons. They are viscous and colorless liquids. Some are used as anesthetics or hypnotics. However, the class is best known for their use as a coolant or antifreeze. Dihydroxyethanes,Ethanediols,Glycols, Ethylene
D006588 Hexanones 6-carbon straight-chain or branched ketones. Butyl Methyl Ketones,Ethyl Propyl Ketones,Ketones, Butyl Methyl,Ketones, Ethyl Propyl,Methyl Ketones, Butyl,Propyl Ketones, Ethyl
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012460 Sulfasalazine A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) Salicylazosulfapyridine,Asulfidine,Azulfadine,Azulfidine,Azulfidine EN,Colo-Pleon,Pleon,Pyralin EN,Salazopyrin,Salazosulfapyridine,Sulfasalazin medac,Sulfasalazin-Heyl,Sulfasalazine FNA,Sulphasalazine,Ucine,Ulcol,ratio-Sulfasalazine,Colo Pleon,Sulfasalazin Heyl,ratio Sulfasalazine

Related Publications

Tamio Fukushima, and Toshinori Yamamoto, and Rie Kikkawa, and Yoshimasa Hamada, and Masatoshi Komiyama, and Chisato Mori, and Ikuo Horii
January 1992, Reproductive toxicology (Elmsford, N.Y.),
Tamio Fukushima, and Toshinori Yamamoto, and Rie Kikkawa, and Yoshimasa Hamada, and Masatoshi Komiyama, and Chisato Mori, and Ikuo Horii
May 2011, Trends in pharmacological sciences,
Tamio Fukushima, and Toshinori Yamamoto, and Rie Kikkawa, and Yoshimasa Hamada, and Masatoshi Komiyama, and Chisato Mori, and Ikuo Horii
January 2011, Spermatogenesis,
Tamio Fukushima, and Toshinori Yamamoto, and Rie Kikkawa, and Yoshimasa Hamada, and Masatoshi Komiyama, and Chisato Mori, and Ikuo Horii
January 2024, Frontiers in cell and developmental biology,
Tamio Fukushima, and Toshinori Yamamoto, and Rie Kikkawa, and Yoshimasa Hamada, and Masatoshi Komiyama, and Chisato Mori, and Ikuo Horii
March 1993, Transgenic research,
Tamio Fukushima, and Toshinori Yamamoto, and Rie Kikkawa, and Yoshimasa Hamada, and Masatoshi Komiyama, and Chisato Mori, and Ikuo Horii
January 2016, International journal of fertility & sterility,
Tamio Fukushima, and Toshinori Yamamoto, and Rie Kikkawa, and Yoshimasa Hamada, and Masatoshi Komiyama, and Chisato Mori, and Ikuo Horii
November 2004, Endocrine,
Tamio Fukushima, and Toshinori Yamamoto, and Rie Kikkawa, and Yoshimasa Hamada, and Masatoshi Komiyama, and Chisato Mori, and Ikuo Horii
January 2006, Trends in reproductive biology,
Tamio Fukushima, and Toshinori Yamamoto, and Rie Kikkawa, and Yoshimasa Hamada, and Masatoshi Komiyama, and Chisato Mori, and Ikuo Horii
January 2004, Environmental sciences : an international journal of environmental physiology and toxicology,
Tamio Fukushima, and Toshinori Yamamoto, and Rie Kikkawa, and Yoshimasa Hamada, and Masatoshi Komiyama, and Chisato Mori, and Ikuo Horii
April 1998, Molecular reproduction and development,
Copied contents to your clipboard!